Lianyungang, China

Xingfeng Ge


Average Co-Inventor Count = 15.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Xingfeng Ge

Introduction

Xingfeng Ge is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for hepatitis B virus infections. With a total of 4 patents to his name, Ge's work is recognized for its potential impact on public health.

Latest Patents

Among his latest patents is a drug combination containing a TLR7 agonist. This innovative combination utilizes a compound that acts as a TLR7 agonist alongside entecavir, aimed at effectively treating hepatitis B virus infections. The drug combination has demonstrated a strong anti-hepatitis B virus infection effect. Another notable patent is for an N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor. This invention includes a compound that can be used in pharmaceutical compositions for treating diseases associated with hepatitis B virus infection.

Career Highlights

Xingfeng Ge is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work at this esteemed company has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. Ge's innovative approach and dedication to improving treatment options have positioned him as a key figure in his field.

Collaborations

Ge has collaborated with several talented individuals in his career, including Dandan Lu and Wei Shi. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Xingfeng Ge's contributions to the pharmaceutical industry, particularly in the realm of hepatitis B treatments, highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to advancing medical science and providing effective solutions for viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…